Aerobic Vaginitis

CPT: 87798×2, 87640, 87653

Test Includes

  • Enterococcus Faecalis
  • Escherichia Coli
  • Staphylococcus Aureus
  • Streptococcus Agalactiae

Expected Turnaround Time

24 hours

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Specimen Requirements

Specimen

Vaginal Swab or ThinPrep

Volume

1ml

Minimum Volume

0.5ml

Container

Liquid Amies Medium or Thinprep vial

Storage Instructions

Room Temp., Refrigerated (2-8 C)

Stability Requirements

Room temp. 48hrs., Refrigerated 72 hours

Test Details

Methodology

PCR

Reference Interval

Not Detected

Additional Information

An Aerobic Vaginitis (AV) Panel detects bacterial pathogens associated with aerobic vaginitis, a vaginal infection characterized by an imbalance in normal flora, inflammation, and disruption of the vaginal epithelium.

The bacterial isolates that are included in the panel includes:

  • Enterococcus faecalis: A facultative anaerobic Gram-positive bacterium commonly found in the gastrointestinal tract but implicated in AV due to its ability to adhere to vaginal epithelial cells and trigger inflammation.
  • Escherichia coli: A Gram-negative rod that can colonize the vagina from the rectal reservoir, leading to AV and increasing the risk of urinary tract infections.
  • Staphylococcus aureus: A Gram-positive coccus capable of producing toxins and biofilms, contributing to vaginal dysbiosis and potential complications like toxic shock syndrome in rare cases.
  • Streptococcus agalactiae (Group B Streptococcus, GBS): A Gram-positive bacterium associated with AV and adverse pregnancy outcomes, including preterm labor and neonatal infections if transmitted during childbirth.

Tempera et al. found that patients with AV have depressed levels of hydrogen-peroxide-producing lactobacilli, but increased levels of aerobic bacteria (group B streptococci, S. aureus, E. coli and enterococci). Compared with the normal vaginal microflora, these aerobes increased by three-to fivefold and were associated with inflamed vaginal mucosa and with evidence of local cytokine-mediated inflammation. Similarly, Wang et al. developed a bedside test for AV diagnosis. AV was diagnosed based on five enzymatic indicators:

  1. Hydrogen peroxidase activity, which reflects the growth status of hydrogen peroxide-producing lactobacilli;
  2. Leucocyte esterase (LE) activity, which indicates the presence of inflammation;
  3. sialidase activity, which is produced in high quantities by BV and AV associated bacteria, S. agalactiae;
  4. Beta-glucuronidase activity, specific for E. coli infection;
  5. Coagulase activity, which indicates the presence of S. aureus and E. faecalis . The authors also found increased presence of E coli, but the methodology used for detection was not clear. The reported sensitivity of their test was 90%, but the study lacked analysis of specificity.

Detection of these bacteria in a vaginal swab using molecular or culture-based methods helps guide appropriate antibiotic treatment to restore vaginal microbiota balance and prevent complications.

Reference:

  • Donders, G. G. G., Ruban, K., & Bellen, G. (2020). Aerobic vaginitis: No longer a stranger. Research in Microbiology, 171(1-2), 75-78. DOI: 10.1016/j.resmic.2019.11.006
  • Donders, G. G., Vereecken, A., Bosmans, E., Dekeersmaecker, A., Salembier, G., & Spitz, B. (2002). Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: Aerobic vaginitis. BJOG: An International Journal of Obstetrics and Gynaecology, 109(1), 34-43. https://doi.org/10.1111/j.1471-0528.2002.01032.x

 

Footnotes

Statement on Medical Necessity
All ordered tests should be medically necessary for the diagnosis or detection of disease, illness, impairment, symptom, syndrome, or disorder and the results should be used in the medical management and treatment decisions for the patient. Solaris requires ICD-10 codes with each order for lab testing and both the tests ordered and the diagnosis should be documented in the provider’s medical record for the patient. The United States Department of Health and Human Services, Office of Inspector General, takes the position that a provider who orders medically unnecessary tests may be subject to civil penalties.

Panels and Profiles
Solaris offers Providers the convenience of ordering test combinations in a group at times with the flexibility to choose appropriate test(s) for individual patients. Providers should only order those tests that he or she believes are medically necessary for each patient, and a lesser inclusive profile or individual tests should be ordered if not all tests in the test combination/profile are medically necessary. All tests offered in a test combination/profile may be ordered separately as individual tests. Solaris encourages clients to contact their Solaris representative if the testing configurations shown do not meet individual needs for any reason, or if some other combination of procedures is needed.

CPT Codes
CPT Codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are the responsibility of the billing party and are listed here for informational purposes. Correct coding may vary from one carrier to another. Solaris may bill specific carriers using codes other than what is shown.

Questions?

For questions or inquiries related to testing please reach out to
customerservice@solarisdx.com or contact us by phone at (844) 550-0308.